Hong Kong Stock Market Moves | Sansei Pharmaceuticals (01530.HK) Surges Nearly 6% Again, Pfizer Plans to Accelerate the Phase III Clinical Trials of 707 Globally

According to the Wise Wealth APP, SANSHENG Pharmaceuticals (01530.HK) rose nearly 6% again, as of the time of publication, it fell 5.1%, at 29.9 Hong Kong dollars, with a turnover of 981 million Hong Kong dollars.